## **Trustees' Annual Report for the period** ||Period start date|Period start date|||Period end date|Period end date|| |---|---|---|---|---|---|---|---| ||01|04|2021||31|03|2022| |**From **||||**To**|||| ## Section A Reference and administration details **Charity name** The Head and Neck Cancer Research Trust **Other names charity is known by** **Registered charity number (if any)** 1180082 **Charity's principal address** Beacon House 113 Kingsway London **Postcode WC2B 6PP** **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**| |---|---|---|---|---| ||Amie Mertens|||| ||Karen Wint|||| ||Vessela Vassileva|||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| **Names of the trustees for the charity, if any, (for example, any custodian trustees)** **Name Dates acted if not for whole year** **TAR** March **2012** 1 ## **Names and addresses of advisers (Optional information)** |**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**| |---|---|---| |**Type of adviser**
**Name**
**Address**||| |||| |||| |||| |||| |**Name of chief executive or names of senior staff members (Optional information)**||| |||| ## **Section B** ## **Structure, governance and management** ## **Description of the charity’s trusts** Constitution Type of governing document (eg. trust deed, constitution) Trust How the charity is constituted - (eg. trust, association, company) New trustees maybe appointed to the board at any time by the trustees. Trustee selection methods Selection is based on skill, knowledge and experience needed for the (eg. appointed by, elected by) effective administration of the CIO ## **Additional governance issues (Optional information)** You **may choose** to include additional information, where relevant, about: - policies and procedures adopted for the induction and training of trustees; - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; - trustees’ consideration of major risks and the system and procedures to manage them. ## **Section C** ## **Objectives and activities** HNCRT aims at advancing research into prevention, early detection and treatment of head and neck cancer, and supporting the research work of the ‘Bench to Bedside Head and Neck Cancer Programme’ led by Dr Matt. Lechner (MD, PhD). **Summary of the objects of the charity set out in its governing document** **TAR** March **2012** 2 The charity aims to increase the awareness of Human Papilloma Virus and to pursue the introduction of the HPV vaccine for boys and men in the UK and worldwide. Work is being carried out develop a test which might enable early detection in respect of HPV-associated oropharyngeal cancer. **Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** ## **Additional details of objectives and activities (Optional information)** You **may choose** to include further statements, where relevant, about: - policy on grantmaking; - policy programme related investment; - contribution made by volunteers. **TAR** March **2012** 3 Section D Achievements and performance TAR Mar¢h 2012 ## Section D Achievements and erformance p **Summary of the main achievements of the charity during the year** **TAR** March **2012** 5 ## **Section E** ## **Financial review** The charity is still in the early stages of becoming established and as such **Brief statement of the** the Trustees have yet to set a formal policy in respect of reserves. The **charity’s policy on reserves** Trustees have full control of the bank account and manage funds accordingly. Once more substantial income streams are in place a formal policy will be documented and adopted. **Details of any funds materially in deficit** N/A ## **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. ## **Section F** ## **Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s)** Amie Mertens **Full name(s)** Amie Mertens **Position (eg Secretary, Chair,** Trustee **etc) Date** 28.01.23 **TAR** March **2012** 6 ||
**The Head and Neck Cancer Research Trust**|
**The Head and Neck Cancer Research Trust**|
**The Head and Neck Cancer Research Trust**|
**The Head and Neck Cancer Research Trust**|
**The Head and Neck Cancer Research Trust**|**CC16a**| |---|---|---|---|---|---|---| ||**For the period**
**from**||Period start date
01/04/2021|**To**||| |||||||| |**Section A Receipts and payments**||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**3,250**
**-**
**19**
**-**
**-**
**-**
**-**
**-**

**3,269**
**-**
**-**
**-**
**3,269**||**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**3,250**
**-**
**19**
**-**
**-**
**-**
**-**
**-**
**3,269**
**-**
**-**
**-**
**3,269**
**16**
**3,000**
**-**
**-**
**-**
**-**
**-**
**-**
**3,016**
**-**
**-**
**-**
**3,016**

**253**|**Last year**
**to the nearest £**| |Donations|**3,250**|||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**-**| ||**-**|||||**-**| |Bank interest|**19**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|
**3,269**|||||**-**| |||||||| |**A2 Asset and investment sales,**
**(see table).**||||||| ||**-**|||**-**
**-**
**-**||| ||**-**|||||**-**| |~~**_Sub total_**~~|**-**|||||**-**| |**_Total receipts_**
**A3 Payments**||||||| |||||**-**||**-**| |||||||| |
Computer costs|**16**||**-**|**-**||**-**| |Grant to UCL|**3,000**||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| ||**-**|||||**-**| |**_Sub total_**|**3,016**|||||**-**| |||||||| |**A4 Asset and investment**
**purchases, (see table)**||||||| ||**-**|||**-**
**-**
**-**||| ||**-**|||||| |**_Sub total_**|**-**|||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**||||||| |||||**-**||**-**| |||||||| ||**253**|||
**-**||**-**| ||**-**|||
**-**
**-**|**-**
**2,014**|**-**| ||**2,014**|||||**-**| ||**2,267**|||
**-**|
**2,267**|**-**| CCXX R1 accounts (SS) 27/01/2023 1 **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
NatWest bank account
**Details**
**Details**
**Details**
Signature
A Mertens|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**2,267**
**-**
**-**
**-**
**-**
**-**
**2,267**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
A Mertens|**Endowment**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Endowment**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| ||A Mertens|A Mertens|28.01.23| ||||| CCXX R2 accounts (SS) 27/01/2023 2